Inhaled steroids for bronchiectasis

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Kapur, Nitin ^a   Bell, Scott ^b   Kolbe, John ^c   Chang, Anne B ^d  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c GREEN LANE HOSPITAL   (New Zealand)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Administration, inhalation; Adrenal cortex hormones *administration dosage ; Adult; Androstadienes administration dosage ; Anti bacterial agents administration dosage ; Beclomethasone administration dosage ; Bronchiectasis *drug therapy ; Humans; Randomized controlled trials as topic; Respiratory function tests

Indexed keywords

BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BIOLOGICAL MARKER; BRONCHODILATING AGENT; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE; IPRATROPIUM BROMIDE; PLACEBO; SALBUTAMOL; THEOPHYLLINE; TRIAMCINOLONE;

ADRENAL INSUFFICIENCY; ASTHMA; BACTERIUM; BRONCHIECTASIS; CATARACT; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; COUGHING; DATA ANALYSIS; DATA EXTRACTION; DATA SYNTHESIS; DENSITY; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG USE; EMBASE; FORCED EXPIRATORY VOLUME; HUMAN; INFORMATION PROCESSING; INTERVENTION STUDY; LUNG FUNCTION; MEDLINE; MORBIDITY; OUTCOME ASSESSMENT; PEAK EXPIRATORY FLOW; PHARYNGEAL CANDIDIASIS; PHARYNGITIS; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY ANALYSIS; SIDE EFFECT; SPIROMETRY; SPUTUM; SYMPTOM; THORAX RADIOGRAPHY; TREATMENT DURATION; VOICE CHANGE; WHEEZING;

EID: 70249110381     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD000996.pub2     Document Type: Review

References (37)

1. Elborn JS, Johnston B, Allen F, Clarke J, McGarry J, Varghese G. Inhaled steroids in patients with bronchiectasis. RespiratoryMedicine 1992;86(2):121-124 [PUBMED: 1615177]
2. Joshi JM, Sundaram P. Role of inhaled steroids in stable bronchiectasis. Indian Practitoner 2004;57(4):243-245
3. Martinez GarciaMA, Perpina-Tordera M, Roman-Sanchez P, Soler - Cataluna JJ. Inhaled steroids improve quality of life in patients with steady state bronchiectasis. RespiratoryMedicine 2006;100:1623-1632 (Pubitemid 44089352)
4. TsangKW,Ho P, LamW, IpM, Chan K,Ho C, et al.Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. American Journal of Respiratory and Critical CareMedicine 1998;158 (3):723-727 [PUBMED: 9730996]
5. Tsang KW, Tan KC, Ho PL, Ooi GC, Khong PL, Leung R, et al.Exhaled nitric oxide in bronchiectasis: the effects of inhaled corticosteroid therapy. International Journal of Tuberculosis and Lung Disease 2004;8(11):1301-1307 (Pubitemid 39611573)
6. Tsang KW, Tan KC, Ho PL, Ooi GC, Ho JC, Mak J, et al.Inhaled fluticasone in bronchiectasis : a 12 month study. Thorax 2005;60: 239-243 [PUBMED: 15741443] (Pubitemid 40380285)
7. Ghosh CS, Joseraj R, Kumari A, Jayaprakash. A randomized controlled clinical trial comparing the effects of inhaled budesonide vs inhaled ipratropium in patients with bronchiectasis. Indian Journal of Allergy Asthma and Immunology 2002;16(1):55-71.
8. Monton C, Ewig S, Torres A, El-Ebiary M, Filella X, Rano A, et al.Role of glucocorticoids on inflammatory response in non-immunosuppressed patients with pneumonia: a pilot study. European Respiratory Journal 1999;14:218-220 (Pubitemid 29411261)
9. O'Neill B, Bradley JM, Macmohan J, Elborn S. Subjective benefit of inhaled therapies in patients with bronchiectasis: a questionnaire study. International Journal of Clinical Practice 2004;58(5):441-443. (Pubitemid 38786563)
10. Abramson MJ, Crockett AJ, Frith PA, McDonald CF. COPDX: an update of guidelines for the management of chronic obstructive pulmonary disease with a review of recent evidence. Medical Journal of Australia 2006;184(7):342-345
11. Balfour-Lynn IM, Lees B, Hall P, et al.Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis. American Journal of Respiratory & Critical Care Medicine 2006;173 (12):1356-1362 (Pubitemid 43900710)
12. Balfour-Lynn I, Walters S, Dezateux C. Inhaled corticosteroids for cystic fibrosis. Cochrane Database of Systematic Reviews 2000, Issue 1. [DOI: DOI: 10.1002/14651858.CD001915]
13. Cates C. Visual Rx. Online NNT Calculator.. http: //www.nntonline.net/: Cates C, 2003.
14. Chang AB, Masel JP, Masters B. Post-infectious bronchiolitis obliterans: clinical, radiological and pulmonary function sequelae. Pediatric Radiology 1998;28(1):23-29 (Pubitemid 28055102)
15. Chang AB, Grimwood K, Mulholland EK,Torzillo PJ. Bronchiectasis in Indigenous children in remote Australian communities. Medical Journal of Australia 2002;177(4):200-204 (Pubitemid 35021432)
16. Chang AB, Bilton D. Exacerbations in cystic fibrosis: 4 - non-cystic fibrosis bronchiectasis. Thorax 2008;63(3):269-276
17. Cole PJ. Inflammation: a two edged sword. Themodel of bronchiectasis. European Journal of Respiratory Disease. Supplement. 1986;147:6-15.
18. Edwards EA, Asher MI, Byrnes CA. Paediatric bronchiectasis in the twenty-first century: experience of a tertiary children's hospital in New Zealand. Journal of Paediatrics & Child Health 2003;39(2):111-117
19. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV,VailA.Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-149 (Pubitemid 34284916)
20. Ellerman A, Bisgaard H. Longitudinal study of lung function in a cohort of primary ciliary dyskinesia. European Respiratroy Journal 1997;10(10):2376- 2379 (Pubitemid 27479564)
21. Field CE, Field CE, Field CE. Bronchiectasis: Third report on a follow-up study of medical and surgical cases from childhood. Archives of Disease in Childhood 1969;44:551-561
22. Gursel G. Does coexistence with bronchiectasis influence intensive care unit outcome in patients with chronic obstructive pulmonary disease?. Heart & Lung 2006;35(1):58-65. (Pubitemid 43106636)
23. IpM, Lauder IJ, Wong WY. Multivariate analysis of factors affecting pulmonary function in bronchiectasis.. Respiration 1993;60:45-50. (Pubitemid 23117207)
24. Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E. Non-cysticfibrosis bronchiectasis in children: a persisting problemin developing countries. Respiration 2005;72(3):233-238 (Pubitemid 40981080)
25. Karakoc GB, Yilmaz M, Altintas DU, Kendirli SG. Bronchiectasis: still a problem. Pediatric Pulmonology 2001;32(2):175-178
26. Keistinen T, Saynajakangas O, Tuuponen T, Kivela SL. Bronchiectasis: an orphan disease with a poorly-understood prognosis. European Respiratory Journal 1997;10(12):2784-2787 (Pubitemid 28052788)
27. Lewis MM, Mortelliti MP, Yeager H, Jr, Tsou E. Clinical bronchiectasis complicating pulmonary sarcoidosis: case series of seven patients. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 2002;19(2):154-159
28. O'Brien C, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000;55(8):635-642 (Pubitemid 30468217)
29. Patel IS, Vlahos I, Wilkinson TM, Lloyd-Owen SJ, Donaldson GC, Wilks M, et al.Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine 2004;170(4):400-407 (Pubitemid 39214614)
30. Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respiratory Medicine 2007;101(6):1163-1170.
31. Singleton R, Morris A, Redding G, Poll J, Holck P, Martinez P, Kruse D, Bulkow LR, Petersen KM, Lewis C. Bronchiectasis in Alaska Native children: causes and clinical courses. Pediatric Pulmonology 2000;29(3):182-187 (Pubitemid 30141794)
32. Sobieraj DM, White CM, Coleman CI. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Clin Ther 2008;30(8):1416-1425
33. Twiss J, StewartAW, ByrnesCA. Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis. Thorax 2006;61(5):414-418 (Pubitemid 43723325)
34. Van Haren EH, Lammers JW, Festen J, et al.The effects of inhaled corticosteroid budesonide on lung function and bronchial hyper-responsiveness in adult patients with cystic fibrosis. Respiratory Medicine 1995;89:209-214
35. Wilson CB, Jones PW, O'Leary CJ, Cole PJ, Wilson R. Validation of the St. George's respiratory questionnaire in bronchiectasis. American Journal of Respiratory & Critical Care Medicine 1997;156:536-541 (Pubitemid 27351991)
36. Yang IA, Fong KM, Sim EH, Black PN, Lasserson TJ. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: DOI: 10.1002/14651858.CD002991.pub2]
37. Ram FS, Wells A, Kolbe J. Inhaled steroids for bronchiectasis. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: DOI: 10.1002/14651858. CD000996] * Indicates the major publication for the study